RxDoctor Payments Data

Patrick Sheets, MD

Family Medicine · Rensselaer, INNPI 1396704268

Payments from drug & device makers

$5,524in general payments, 2019–2025

Across 383 payments — averaging $14.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Bayer$547
  • AstraZeneca$292
  • Johnson & Johnson$276
  • Avanir Pharmaceuticals, Inc.$262
  • Electromed, Inc.$217
  • plus $2K from 42 others

What the payments were for

  • Food & beverage$5,524100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,524 in reported general payments places this provider in the 85th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$181,659
Medicare patients
506
Services billed
8,910

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban234$147,334
TrulicityDulaglutide90$100,549
MounjaroTirzepatide69$90,707
OzempicSemaglutide82$87,634
XareltoRivaroxaban83$64,397
JanuviaSitagliptin Phosphate48$58,187
JardianceEmpagliflozin50$57,425
CreonLipase/Protease/Amylase22$27,238
MyrbetriqMirabegron50$25,473
FarxigaDapagliflozin Propanediol27$22,392
LinzessLinaclotide23$20,653
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog69$16,488
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen799$15,580
EntrestoSacubitril/Valsartan14$12,591
OxycontinOxycodone Hcl31$11,328

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$177$191,255159 claims
PfizerEliquis$138$147,334234 claims
Novo NordiskOzempic$170$87,63482 claims
Boehringer IngelheimJardiance, Combivent Respimat$62$67,29164 claims
Johnson & JohnsonXarelto$276$64,39783 claims
MerckJanuvia$55$58,18748 claims
AbbVieCreon, Linzess$1,442$47,89245 claims
Astellas Pharma US IncMyrbetriq$171$25,47350 claims
AstraZenecaFarxiga$292$22,39227 claims
NovartisEntresto$110$12,59114 claims
Avanir Pharmaceuticals, Inc.Nuedexta$262$11,19525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Rensselaer

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →